| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.082 | 0.2 |